Description
Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer’s disease. Donanemab was approved for medical use in the United States in July 2024 by the Food and Drug Administration. Treatment is intended for patients with mild cognitive impairment or mild dementia stage of disease, which is the same population the treatment was studied in the clinical trials.
Donanemab is indicated for the treatment of Alzheimer’s disease for people with mild cognitive impairment or mild dementia stage of disease.
Get Access to KISUNLA (donanemab-azbt) In India
Medvitaz Pharma is equipped to facilitate the distribution of KISUNLA (donanemab-azbt) (prescription medications) worldwide and throughout India upon completion of necessary legal procedures, if applicable.
To inquire about the price of either the branded medication “KISUNLA (donanemab-azbt)” or the generic version “donanemab-azbt” for personal use under patient-specific treatment in various cities including Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim, and others in India, please fill out the request form. Upon receiving your request and assessing the delivery process, we will provide you with an estimated price for the medication within 24 hours.
For any inquiries or assistance, please reach out to our Patient Support Team. We are available to assist you from Monday to Friday, between 9:00 and 19:00 IST. You can contact us via email at [email protected], toll-free at +91 8750295029, or through WhatsApp at +91-8750295029.